NYSE:XYL
Xylem Inc Stock News
$143.32
+0.640 (+0.449%)
At Close: May 17, 2024
Xylem (XYL) Beats on Q4 Earnings & Revenues, Hikes Dividend
05:26pm, Tuesday, 07'th Feb 2023 Zacks Investment Research
Xylem's (XYL) Q4 results benefit from strong performances across all segments and higher organic sales. Simultaneously, the company hikes dividend by 10%.
Xylem (XYL) Q4 Earnings and Revenues Top Estimates
01:35pm, Tuesday, 07'th Feb 2023 Zacks Investment Research
Xylem (XYL) delivered earnings and revenue surprises of 15% and 6.43%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Xylem Inc. (XYL) Q4 2022 Earnings Call Transcript
01:08pm, Tuesday, 07'th Feb 2023
Xylem Inc. (NYSE:XYL ) Q4 2022 Results Conference Call February 7, 2023 9:00 AM ET Company Participants Andrea van der Berg - VP, IR Patrick Decker - CEO Sandy Rowland - CFO Matthew Pine - CCO Confere
Xylem (XYL) Q4 Earnings and Revenues Top Estimates
09:47am, Tuesday, 07'th Feb 2023
Xylem (XYL) delivered earnings and revenue surprises of 15% and 6.43%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Q4 Corporate Earnings Move in the Opposite Direction of Economic Indicators
05:50pm, Monday, 06'th Feb 2023 Investing.comShould You Buy Xylem (XYL) Ahead of Earnings?
02:07pm, Monday, 06'th Feb 2023 Zacks Investment Research
Xylem (XYL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Why Xylem (XYL) Could Beat Earnings Estimates Again
05:10pm, Friday, 03'rd Feb 2023 Zacks Investment Research
Xylem (XYL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Xylem (XYL) Could Beat Earnings Estimates Again
01:33pm, Friday, 03'rd Feb 2023
Xylem (XYL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
RBC Bearings (RBC) Reports Next Week: Wall Street Expects Earnings Growth
03:01pm, Thursday, 02'nd Feb 2023 Zacks Investment Research
RBC Bearings (RBC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Parker-Hannifin (PH) Q2 Earnings and Revenues Surpass Estimates
01:55pm, Thursday, 02'nd Feb 2023 Zacks Investment Research
Parker-Hannifin (PH) delivered earnings and revenue surprises of 6.97% and 4.78%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Ball Corp (BALL) to Report Q4 Earnings: What's in Store?
05:38pm, Tuesday, 31'st Jan 2023 Zacks Investment Research
Ball Corporation's (BALL) Q4 results are likely to reflect the recent deceleration of customer demand, particularly in the United States, as well as elevated raw material and manufacturing costs.
Xylem (XYL) Reports Next Week: Wall Street Expects Earnings Growth
03:00pm, Tuesday, 31'st Jan 2023 Zacks Investment Research
Xylem (XYL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Xylem (XYL) Reports Next Week: Wall Street Expects Earnings Growth
11:45am, Tuesday, 31'st Jan 2023
Xylem (XYL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Avery Dennison (AVY) to Report Q4 Earnings: What's in Store?
02:27pm, Monday, 30'th Jan 2023 Zacks Investment Research
Avery Dennison's (AVY) Q4 results are likely to reflect the impacts of raw material and freight cost inflation, unfavorable currency translation, and supply-chain issues, offset by strong demand.
Grainger (GWW) Set to Report Q4 Earnings: What's in Store?
02:25pm, Monday, 30'th Jan 2023 Zacks Investment Research
Grainger's (GWW) fourth-quarter performance is likely to have benefited from strong growth in the non-pandemic product sales volume and gains from cost-reduction actions.